{"id":"W4376129366","doi":"10.1016/j.pcad.2023.05.002","title":"Biomarkers for the Diagnosis of Heart Failure in People with Diabetes: A Consensus Report from Diabetes Technology Society","year":2023,"lang":"en","type":"review","venue":"Progress in Cardiovascular Diseases","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute on Minority Health and Health Disparities; National Institute on Aging; Relypsa; Dexcom; National Institutes of Health; Esperion Therapeutics; Gilead Sciences; Servier; Impulse Dynamics; Tandem Diabetes Care; Novo Nordisk; ReCor Medical; Cytokinetics; MannKind Corporation; Pfizer; Insulet Corporation; Vifor Pharma; LivaNova; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Amgen; American Regent; Kowa Company; Sanofi; American Heart Association","keywords":"Medicine; Biomarker; Diabetology; Natriuretic peptide; Intensive care medicine; Diabetes mellitus; Internal medicine; Type 2 diabetes; Heart failure; Stage (stratigraphy); Asymptomatic; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05234811,0.002036501,0.003513141,0.005676721,0.001213304,0.003617381,0.006187985,0.006703146,0.001252444],"category_scores_gemma":[0.03352701,0.001024969,0.005994159,0.003845007,0.001173409,0.002715894,0.003899045,0.01107595,0.001767432],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004299498,"about_ca_system_score_gemma":0.01968641,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01737872,"about_ca_topic_score_gemma":0.01173598,"domain_scores_codex":[0.9818409,0.00527993,0.004720863,0.001231205,0.005991578,0.0009354813],"domain_scores_gemma":[0.9362208,0.01413775,0.004828723,0.001140118,0.03965815,0.00401435],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003883413,0.0003447529,0.01250493,0.009560876,0.0009548113,0.0004755363,0.0006398424,0.0009764949,0.001204141,0.004009434,0.5800151,0.3889257],"study_design_scores_gemma":[0.0008758703,0.0004861083,0.03866623,0.03518885,0.003581035,0.001665717,0.001176347,0.002614226,0.002279373,0.007721092,0.905442,0.0003032348],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005609018,0.5653777,0.0250801,0.3346969,0.0459056,0.002394672,0.005519852,0.0006531872,0.01476304],"genre_scores_gemma":[0.04130485,0.6390622,0.137867,0.1191261,0.02433356,0.005452853,0.02239878,0.0002695167,0.01018509],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.05234811,"threshold_uncertainty_score":0.2768466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02630321318965317,"score_gpt":0.3065248081521089,"score_spread":0.2802215949624557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}